When Can I Appeal My Health Insurance Carrier’s Decision?
That depends on where you sit.
Tag Archives: reimbursement
CMS Reveals Rationale for NTAP Decisions in Rule Making
What can we learn about how new technologies become eligible for additional payment?
How to Succeed in Japan’s Medical Device Market
After preparing for three key issues, follow these recommended strategies when pursuing the market in Japan.
Transition to ICD-10: Potential Challenges & Benefits for U.S. Payers
Payer organizations face a host of issues in the conversion to ICD-10.
The Best Value Proposition. Ever.
Identify the roadmap through which you’re evolving with the changing healthcare landscape.
Six Concepts to Navigate Manufacturer-Sponsored Clinical Trials
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
What you need to learn before thinking about seeking Medicare reimbursement for a clinical trial.
Engaging ACOs: A How-To for Life Science Companies
Successful accountable care organizations consist of a superior confluence of quality efforts, physician engagement, patient engagement, the right administration and the ability to keep costs down. The challenge comes in balancing these efforts while keeping costs to a minimum.
What Manufacturers Should Know About Reimbursement and Case Management Hotlines for Providers
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.
Living with a Legacy – Reimbursement Barriers Based on Technologies that Came Before
Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.
Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.
Seeking Reimbursement During IDE Clinical Trials
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.
